|

Equities fall sharply on a round of bad news

A host of poor earnings reports have hit UK stocks hard, pushing the FTSE 100 down 100 points in early trading.

  • Bad economic and corporate news sends indices into retreat.

  • FTSE 100 heads back to 6000.

  • Both UK-focused and international firms under pressure.

A double-digit percentage decline in the German economy  and abysmal results from Lloyds have put the cat among the pigeons this morning. Stocks are firmly in the red, with the FTSE 100 taking it on the chin as Lloyds drops 8% and heavy losses in Europe as well as investors fear that more bad news will be on the way. Continuing indications of a rise in virus cases throughout Europe have added to the caution, with markets worrying that Q2 was not the last quarter of significant economic weakness. The FTSE 100, the serial underperformer of the past four months, is now heading back towards 6000, having seen upward momentum stall over the past two months around the 6300 mark. The economic worries have combined with a modest recovery in the dollar to hit commodity prices, putting mining stocks on the back foot as well, leaving London’s main market looking very vulnerable indeed. UK investors will be glad that Shell got its bad news out of the way last month, otherwise today’s numbers would have caused a bigger fall in the stock and put yet more pressure on the beleaguered index.

There was a flurry of UK corporate news this morning, almost all of it bad. Lloyds is paying the price for its dominant position in the UK market, with increasing signs of weakness in the second half, but even international firms like Compass cannot afford to be too optimistic about the rest of the year. Taken together, this is a very gloomy set of updates that should give investors pause before putting more money to work in equities, at least for the time being.

Ahead of the open, we expect the Dow to start at 26,270, down 269 points from Wednesday’s close.

Author

More from Chris Beauchamp
Share:

Editor's Picks

EUR/USD tests 1.1800 barrier above 50-day EMA

EUR/USD gains ground after three days of losses, trading around 1.1790 during the Asian hours on Thursday. The 14-day Relative Strength Index momentum indicator at 47 (neutral) reflects easing momentum. The RSI below 50 keeps momentum balanced and could limit follow-through.

GBP/USD struggles near four-week low vs. USD, below 1.3500 amid BoE rate cut bets

The GBP/USD pair is seen consolidating its weekly losses registered over the past three days and oscillating in a narrow range near a four-week trough, touched during the Asians session on Thursday. Spot prices currently trade just below the 1.3500 psychological mark and seem vulnerable to slide further.

Gold consolidates below $5,000 amid geopolitical risk, hawkish FOMC Minutes

Gold extends its sideways consolidative price move through the Asian session on Thursday and remains below the $5,000 psychological mark as traders seem hesitant amid mixed cues. The US Dollar preserves its strong gains to over a one-week high in the wake of somewhat hawkish Minutes of the US Federal Reserve’s January monetary policy meeting. 

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Mixed UK inflation data no gamechanger for the Bank of England

Food inflation plunged in January, but service sector price pressure is proving stickier. We continue to expect Bank of England rate cuts in March and June. The latest UK inflation read is a mixed bag for the Bank of England, but we doubt it drastically changes the odds of a March rate cut.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.